Cargando…

Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer

BACKGROUND: Surgeons aim for R0 resection in patients with pancreatic cancer to improve overall survival. However, it is unclear whether recent changes in pancreatic cancer care such as centralization, increased use of neoadjuvant therapy, minimally invasive surgery, and standardized pathology repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustinus, Simone, Schafrat, Pascale J. M., Janssen, Boris V., Bonsing, Bert A., Brosens, Lodewijk A. A., Busch, Olivier R., Crobach, Stijn, Doukas, Michail, van Eijck, Casper H., van der Geest, Lydia G. M., Groot Koerkamp, Bas, de Hingh, Ignace H. J. T., Raicu, G. Mihaela, van Santvoort, Hjalmar C., van Velthuysen, Marie-Louise, Verheij, Joanne, Besselink, Marc G., Farina Sarasqueta, Arantza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319672/
https://www.ncbi.nlm.nih.gov/pubmed/37210448
http://dx.doi.org/10.1245/s10434-023-13465-9
_version_ 1785068289115815936
author Augustinus, Simone
Schafrat, Pascale J. M.
Janssen, Boris V.
Bonsing, Bert A.
Brosens, Lodewijk A. A.
Busch, Olivier R.
Crobach, Stijn
Doukas, Michail
van Eijck, Casper H.
van der Geest, Lydia G. M.
Groot Koerkamp, Bas
de Hingh, Ignace H. J. T.
Raicu, G. Mihaela
van Santvoort, Hjalmar C.
van Velthuysen, Marie-Louise
Verheij, Joanne
Besselink, Marc G.
Farina Sarasqueta, Arantza
author_facet Augustinus, Simone
Schafrat, Pascale J. M.
Janssen, Boris V.
Bonsing, Bert A.
Brosens, Lodewijk A. A.
Busch, Olivier R.
Crobach, Stijn
Doukas, Michail
van Eijck, Casper H.
van der Geest, Lydia G. M.
Groot Koerkamp, Bas
de Hingh, Ignace H. J. T.
Raicu, G. Mihaela
van Santvoort, Hjalmar C.
van Velthuysen, Marie-Louise
Verheij, Joanne
Besselink, Marc G.
Farina Sarasqueta, Arantza
author_sort Augustinus, Simone
collection PubMed
description BACKGROUND: Surgeons aim for R0 resection in patients with pancreatic cancer to improve overall survival. However, it is unclear whether recent changes in pancreatic cancer care such as centralization, increased use of neoadjuvant therapy, minimally invasive surgery, and standardized pathology reporting have influenced R0 resections and whether R0 resection remains associated with overall survival. METHODS: This nationwide retrospective cohort study included consecutive patients after pancreatoduodenectomy (PD) for pancreatic cancer from the Netherlands Cancer Registry and the Dutch Nationwide Pathology Database (2009–2019). R0 resection was defined as > 1 mm tumor clearance at the pancreatic, posterior, and vascular resection margins. Completeness of pathology reporting was scored on the basis of six elements: histological diagnosis, tumor origin, radicality, tumor size, extent of invasion, and lymph node examination. RESULTS: Among 2955 patients after PD for pancreatic cancer, the R0 resection rate was 49%. The R0 resection rate decreased from 68 to 43% (2009–2019, P < 0.001). The extent of resections in high-volume hospitals, minimally invasive surgery, neoadjuvant therapy, and complete pathology reports all significantly increased over time. Only complete pathology reporting was independently associated with lower R0 rates (OR 0.76, 95% CI 0.69–0.83, P < 0.001). Higher hospital volume, neoadjuvant therapy, and minimally invasive surgery were not associated with R0. R0 resection remained independently associated with improved overall survival (HR 0.72, 95% CI 0.66–0.79, P < 0.001), as well as in the 214 patients after neoadjuvant treatment (HR 0.61, 95% CI 0.42–0.87, P = 0.007). CONCLUSIONS: The nationwide rate of R0 resections after PD for pancreatic cancer decreased over time, mostly related to more complete pathology reporting. R0 resection remained associated with overall survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-023-13465-9.
format Online
Article
Text
id pubmed-10319672
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-103196722023-07-06 Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer Augustinus, Simone Schafrat, Pascale J. M. Janssen, Boris V. Bonsing, Bert A. Brosens, Lodewijk A. A. Busch, Olivier R. Crobach, Stijn Doukas, Michail van Eijck, Casper H. van der Geest, Lydia G. M. Groot Koerkamp, Bas de Hingh, Ignace H. J. T. Raicu, G. Mihaela van Santvoort, Hjalmar C. van Velthuysen, Marie-Louise Verheij, Joanne Besselink, Marc G. Farina Sarasqueta, Arantza Ann Surg Oncol Pancreatic Tumors BACKGROUND: Surgeons aim for R0 resection in patients with pancreatic cancer to improve overall survival. However, it is unclear whether recent changes in pancreatic cancer care such as centralization, increased use of neoadjuvant therapy, minimally invasive surgery, and standardized pathology reporting have influenced R0 resections and whether R0 resection remains associated with overall survival. METHODS: This nationwide retrospective cohort study included consecutive patients after pancreatoduodenectomy (PD) for pancreatic cancer from the Netherlands Cancer Registry and the Dutch Nationwide Pathology Database (2009–2019). R0 resection was defined as > 1 mm tumor clearance at the pancreatic, posterior, and vascular resection margins. Completeness of pathology reporting was scored on the basis of six elements: histological diagnosis, tumor origin, radicality, tumor size, extent of invasion, and lymph node examination. RESULTS: Among 2955 patients after PD for pancreatic cancer, the R0 resection rate was 49%. The R0 resection rate decreased from 68 to 43% (2009–2019, P < 0.001). The extent of resections in high-volume hospitals, minimally invasive surgery, neoadjuvant therapy, and complete pathology reports all significantly increased over time. Only complete pathology reporting was independently associated with lower R0 rates (OR 0.76, 95% CI 0.69–0.83, P < 0.001). Higher hospital volume, neoadjuvant therapy, and minimally invasive surgery were not associated with R0. R0 resection remained independently associated with improved overall survival (HR 0.72, 95% CI 0.66–0.79, P < 0.001), as well as in the 214 patients after neoadjuvant treatment (HR 0.61, 95% CI 0.42–0.87, P = 0.007). CONCLUSIONS: The nationwide rate of R0 resections after PD for pancreatic cancer decreased over time, mostly related to more complete pathology reporting. R0 resection remained associated with overall survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-023-13465-9. Springer International Publishing 2023-05-20 2023 /pmc/articles/PMC10319672/ /pubmed/37210448 http://dx.doi.org/10.1245/s10434-023-13465-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Pancreatic Tumors
Augustinus, Simone
Schafrat, Pascale J. M.
Janssen, Boris V.
Bonsing, Bert A.
Brosens, Lodewijk A. A.
Busch, Olivier R.
Crobach, Stijn
Doukas, Michail
van Eijck, Casper H.
van der Geest, Lydia G. M.
Groot Koerkamp, Bas
de Hingh, Ignace H. J. T.
Raicu, G. Mihaela
van Santvoort, Hjalmar C.
van Velthuysen, Marie-Louise
Verheij, Joanne
Besselink, Marc G.
Farina Sarasqueta, Arantza
Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
title Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
title_full Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
title_fullStr Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
title_full_unstemmed Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
title_short Nationwide Impact of Centralization, Neoadjuvant Therapy, Minimally Invasive Surgery, and Standardized Pathology Reporting on R0 Resection and Overall Survival in Pancreatoduodenectomy for Pancreatic Cancer
title_sort nationwide impact of centralization, neoadjuvant therapy, minimally invasive surgery, and standardized pathology reporting on r0 resection and overall survival in pancreatoduodenectomy for pancreatic cancer
topic Pancreatic Tumors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319672/
https://www.ncbi.nlm.nih.gov/pubmed/37210448
http://dx.doi.org/10.1245/s10434-023-13465-9
work_keys_str_mv AT augustinussimone nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT schafratpascalejm nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT janssenborisv nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT bonsingberta nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT brosenslodewijkaa nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT buscholivierr nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT crobachstijn nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT doukasmichail nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT vaneijckcasperh nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT vandergeestlydiagm nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT grootkoerkampbas nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT dehinghignacehjt nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT raicugmihaela nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT vansantvoorthjalmarc nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT vanvelthuysenmarielouise nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT verheijjoanne nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT besselinkmarcg nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT farinasarasquetaarantza nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer
AT nationwideimpactofcentralizationneoadjuvanttherapyminimallyinvasivesurgeryandstandardizedpathologyreportingonr0resectionandoverallsurvivalinpancreatoduodenectomyforpancreaticcancer